Skip to content

Effect of Neuromuscular Electrical Stimulation Versus Cycle Ergometer Training in a Pulmonary Rehabilitation Program

Effect of Neuromuscular Electrical Stimulation Versus Cycle Ergometer Training in a Pulmonary Rehabilitation Program

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02656667
Acronym
ESNM
Enrollment
102
Registered
2016-01-15
Start date
2016-06-08
Completion date
2019-03-21
Last updated
2025-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Keywords

COPD pulmonary rehabilitation, neuromuscular electrical stimulation, sit to stand test COPD, quadriceps strengthening

Brief summary

The aim of this study is to evaluate the effectiveness of quadriceps strengthening with neuromuscular electrical stimulation versus cycle ergometer as part of pulmonary rehabilitation program , in patients with severe or very severe COPD , according to GOLD with BODE index ≥ 5 .

Detailed description

It's a prospective ,multicentre,randomised, single-blind study which compare the effectiveness of quadriceps strengthening with neuromuscular electrical stimulation versus cycle ergometer training as part of pulmonary rehabilitation program. The program lasts from 3 to 4 weeks. 102 patients will included, diagnosed with COPD stages GOLD III and IV, and BODE index ≥ 5. The commun program: training protocol performed on treadmill,quadriceps resistance training,patient therapeutic education,collective gymnastics,relaxation, session psychological care, smoking cessation program and nutritional management if necessary. The primary criterion is the one minute sit to stand test.

Interventions

DEVICEneuromuscular electrical stimulation

quadriceps strenghthening with neuromuscular electrical stimulation (medical device)

quadriceps strenghthening with cycle ergometer training

excercise training on treadmill

Sponsors

University Hospital, Brest
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with COPD stage 3 or 4, with BODE index ≥ 5 * Hospitalized in the pulmonary rehabilitation unit in the hospital of Morlaix or in the center Les Acacias of briançon, with a 3 at 4 weeks pulmonary rehabilitation course;

Exclusion criteria

* FEV ≥ 50% * Pneumonectomy, Lobectomy less than 6 months * Contraindications to muscle electrostimulation quadriceps * Absence of written consent * Inability to follow the respiratory rehabilitation program in its entirety * People equipped with electronic devices such as pacemakers and intracardiac defibrillators * Skin lesions and infectious foci on the electrode placement area.

Design outcomes

Primary

MeasureTime frameDescription
functional capacity of the lower limb muscles21 - 4 days / +7 daysMeasure of the functional capacity of the lower limb muscles with the 1 minute Sit To Stand Test

Secondary

MeasureTime frameDescription
isometric voluntary quadriceps endurance assessment21 - 4 days / +7 daysMeasure of isometric voluntary quadriceps endurance assessment with handheld dynamometer
assessment of exercise capacity21 - 4 days / +7 daysSix minute walking test for assessing exercise capacity
Quality of Life Assessment21 - 4 days / +7 daysCOPD assessment test for assessing quality of life
Maximal isometric voluntary quadriceps strength assessment21 - 4 days / +7 daysQuadriceps strength assessment with handheld dynamometer
Dyspnea Assessment with MRC Scale21 - 4 days / +7 daysMeasure of dyspnea with Medical Research Council Dyspnea Scale
Dyspnea Assessment with Dyspnea 12 questionnary21 - 4 days / +7 daysMeasure of dyspnea with Dyspnea 12 questionnary
Inspiratory capacity (in litres) by spirometry21 - 4 days / +7 daysMeasure of inspiratory capacity (in litres) by spirometry
Dyspnea Assessment with Borg scale21 - 4 days / +7 daysMeasure of dyspnea with Borg scale at the end of the six minute walking test

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026